Clearside Biomedical Inc (FRA:CLM)
€ 1.02 0.01 (0.99%) Market Cap: 79.38 Mil Enterprise Value: 53.06 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

Q3 2022 Clearside Biomedical Inc Earnings Call Transcript

Nov 09, 2022 / 01:30PM GMT
Release Date Price: €1.24 (-9.16%)
Operator

Good morning, ladies and gentlemen, and welcome to the Clearside Biomedical Inc third quarter 2022 Earnings Call. (Operator Instructions)

It is now my pleasure to turn the floor over to your host, Jenny Kobin, with Investor Relations. Ma'am, the floor is yours.

Jenny R. Kobin
Clearside Biomedical, Inc. - Head of IR

Good morning, and thank you for joining us on the call this morning. On today's call, we will have a brief discussion around Clearside's third quarter financials, followed by the results from the OASIS Phase I/IIa clinical trial. Before we begin, I would like to remind you that during today's call, we'll be making certain forward-looking statements. Various remarks that we may make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot